A rendering of 580 Dubuque Avenue. (Credit: DES Architects + Engineers)
May 8, 2020 09:47 AM EDTUpdated June 5, 12:04 AM
Deals
R&D

Amid lab space scarci­ty, a life sci­ences com­plex to rise in South San Fran­cis­co hub

Amber Tong

The ever-ex­pand­ing group of biotechs mov­ing in­to Oys­ter Point can now ex­pect new neigh­bors as the boom­ing life sci­ences hub in South San Fran­cis­co con­tin­ues …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times